Design and testing of a humanized porcine donor for xenotransplantation
Author:
Anand Ranjith P., Layer Jacob V., Heja David, Hirose TakayukiORCID, Lassiter GraceORCID, Firl Daniel J.ORCID, Paragas Violette B., Akkad Adam, Chhangawala SagarORCID, Colvin Robert B.ORCID, Ernst Russell J., Esch Nicholas, Getchell Kristen, Griffin Alexandra K., Guo Xiaoyun, Hall Katherine C.ORCID, Hamilton Paula, Kalekar Lokesh A.ORCID, Kan Yinan, Karadagi AhmadORCID, Li FengORCID, Low Susan C., Matheson RudyORCID, Nehring Claudia, Otsuka Ryo, Pandelakis Matthew, Policastro Robert A., Pols Rebecca, Queiroz Luis, Rosales Ivy A.ORCID, Serkin William T.ORCID, Stiede KathrynORCID, Tomosugi ToshihideORCID, Xue Yongqiang, Zentner Gabriel E.ORCID, Angeles-Albores David, Chris Chao J., Crabtree Juliet N., Harken Sierra, Hinkle Nicole, Lemos Tania, Li Mailin, Pantano Lorena, Stevens Denise, Subedar Omar D., Tan Xiaoqing, Yin Shiyi, Anwar Imran J.ORCID, Aufhauser DavidORCID, Capuano Saverio, Kaufman Dixon B.ORCID, Knechtle Stuart J., Kwun JeanORCID, Shanmuganayagam DhanansayanORCID, Markmann James F.ORCID, Church George M.ORCID, Curtis Mike, Kawai TatsuoORCID, Youd Michele E.ORCID, Qin WenningORCID
Abstract
AbstractRecent human decedent model studies1,2 and compassionate xenograft use3 have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation and long-term life-supporting function of kidney grafts from a genetically engineered porcine donor transplanted into a cynomolgus monkey model. The porcine donor was engineered to carry 69 genomic edits, eliminating glycan antigens, overexpressing human transgenes and inactivating porcine endogenous retroviruses. In vitro functional analyses showed that the edited kidney endothelial cells modulated inflammation to an extent that was indistinguishable from that of human endothelial cells, suggesting that these edited cells acquired a high level of human immune compatibility. When transplanted into cynomolgus monkeys, the kidneys with three glycan antigen knockouts alone experienced poor graft survival, whereas those with glycan antigen knockouts and human transgene expression demonstrated significantly longer survival time, suggesting the benefit of human transgene expression in vivo. These results show that preclinical studies of renal xenotransplantation could be successfully conducted in nonhuman primates and bring us closer to clinical trials of genetically engineered porcine renal grafts.
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Reference50 articles.
1. Montgomery, R. A. et al. Results of two cases of pig-to-human kidney xenotransplantation. N. Engl. J. Med. 386, 1889–1898 (2022). 2. Porrett, P. M. et al. First clinical‐grade porcine kidney xenotransplant using a human decedent model. Am. J. Transplant. 22, 1037–1053 (2022). 3. Griffith, B. P. et al. Genetically modified porcine-to-human cardiac xenotransplantation. N. Engl. J. Med. 387, 35–44 (2022). 4. Adams, A. B. et al. Anti-C5 antibody tesidolumab reduces early antibody-mediated rejection and prolongs survival in renal xenotransplantation. Ann. Surg. 274, 473–480 (2021). 5. Iwase, H. et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts. Xenotransplantation 24, e12293 (2017).
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|